BRITTNEY VALENTINE: Open Payments
NPI 1831441997 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 45 payments from 10 companies in 2025. Trend: 2023 $517 · 2024 $723 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $177 |
| AstraZeneca Pharmaceuticals LP | 9 | $146 |
| GlaxoSmithKline, LLC. | 6 | $99 |
| PFIZER INC. | 5 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, UBRELVY, CREON, Kerendia, NURTEC ODT, ZENPEP, Ozempic.
Industry payments across OH — which companies pay providers there.
